(VIANEWS) – Shares of Xenetic Biosciences (NASDAQ: XBIO) fell 9.27% to $0.87 at 13:32 EST on Tuesday, following the last session’s downward trend. NASDAQ is falling 1.51% to $12,453.12, after two successive sessions in a row of losses. This seems, so far, an all-around bearish trend trading session today.
Xenetic Biosciences’s last close was $0.92, 83.74% under its 52-week high of $5.68.
Today’s last reported volume for Xenetic Biosciences is 46756 which is 19.85% below its average volume of 58337.
Xenetic Biosciences’s Sales
Xenetic Biosciences’s sales growth is 72.4% for the ongoing quarter and a decline by 33.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 90% and 6.3%, respectively.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.
Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 1.21%, 0.76%, and 3.21%, respectively.
Xenetic Biosciences’s highest amplitude of average volatility was 2.49% (last week), 3.40% (last month), and 3.21% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be oversold (<=20).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $0.87 at 13:32 EST, way below its 52-week low of $1.21.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s worth is way under its 50-day moving average of $1.64 and way below its 200-day moving average of $2.19.
More news about Xenetic Biosciences (XBIO).